In patients with an unexpected hyper-response to FSH, decreasing the FSH dose during treatment may reduce the occurrence of OHSS; with moderate-to-severe OHSS estimated to arise in 0.5 to 5.0% of IVF cycles [45, 46]. Here, BRD2 is linked to ovarian hyperstimulation syndrome.